Gefitinib
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9338 publications
Corrigendum to "Marsdenia tenacissima extract potentiates the anti-lung cancer efficacy of gefitinib through dual regulation of the Wnt pathway and ferroptosis" [J. Ethnopharmacol. 359 (2026) 121121].
Journal: Journal of ethnopharmacology
Published: June 23, 2026
Maximizing Lipidome Coverage of Mouse Liver Following the IV Administration of Gefitinib by Combining Both UHPLC-MS-Based Untargeted and Targeted Lipidomics.
Journal: Journal of proteome research
Published: June 13, 2026
Exploring the potential of multiple receptors overexpressed on glioblastoma cells as biomarkers for the targeted therapy; a review.
Journal: Therapeutic delivery
Published: June 11, 2026
CAMK2D isoform 15 facilitates gefitinib resistance via AKT phosphorylation in lung adenocarcinoma.
Journal: Cancer biology & medicine
Published: May 19, 2026
Gender Differences in EGFR-TKI-Related Adverse Events: A Pharmacovigilance Study Based on the FAERS Database.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: May 16, 2026
Galangin Overcomes Gefitinib and Sotorasib Resistance in Non-small Cell Lung Cancer by Inhibiting Efferocytosis.
Journal: Journal of agricultural and food chemistry
Published: April 20, 2026
Design, Synthesis of Novel Quinazolinone Derivatives and Evaluation of EGFR Kinase Inhibition Activity via In Vitro and In Silico Studies.
Journal: Chemical biology & drug design
Published: April 13, 2026
3-Formylchromone attenuates urethane-induced lung carcinogenesis and enhances gefitinib anti-tumor response via modulation of IL-6/JAK1/STAT3/cyclin D1 signaling.
Journal: Toxicology mechanisms and methods
Published: April 11, 2026
Multi-omics analysis identified SPRR2D as a potential biomarker for tumor prognosis and immune microenvironment infiltration: a pan-cancer perspective.
Journal: Future science OA
Published: April 04, 2026
EGFR suppression mediates aurantio-obtusin-induced autophagy-dependent ferroptosis in breast cancer cells.
Journal: Toxicology and applied pharmacology
Published: April 01, 2026
Correction to "The Underlying Mechanism Involved in Gefitinib Resistance and Corresponding Experiment Validation in Lung Cancer".
Journal: Mediators of inflammation
Published: March 28, 2026
New benzochromene-based compounds as potential EGFR-TK inhibitors: synthesis, anti-proliferative activity, molecular docking studies, and ADME profiles.
Journal: RSC advances
Published: March 24, 2026
Last Updated: 06/30/2026